查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1986797

慢性阻塞性肺病和气喘治疗设备市场报告：按产品、适应症、通路和地区划分（2026-2034 年）

COPD and Asthma Devices Market Report by Product (Inhalers, Nebulizers), Indication (Asthma, COPD), Distribution Channel (Retail Pharmacies, Hospitals, Online Pharmacies), and Region 2026-2034
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3个工作天内

价格

2025年，全球慢性阻塞性肺病和气喘治疗设备市场规模达499亿美元。展望未来，IMARC集团预测，到2034年，该市场规模将达到725亿美元，2026年至2034年的复合年增长率（CAGR）为4.24%。市场成长的主要驱动因素包括：具备即时监测功能的智慧吸入器技术的持续进步；呼吸系统疾病盛行率的上升；人们对更精准给药的个人化治疗日益关注；以及新兴市场由于医疗保健服务改善而带来的需求成长。

慢性阻塞性肺病（COPD）是一种发炎性疾病，会导致肺部气流受阻。其初期症状包括呼吸困难、喘息、胸闷、慢性咳嗽（伴随或不伴随痰）、频繁感冒和咽喉痛。气喘，也称为支气管气喘，是一种影响肺部气道的呼吸系统疾病。其症状包括呼吸困难、胸闷、睡眠障碍、咳嗽和喘息发作。这些呼吸系统疾病的治疗方法是使用各种辅助吸入药物的装置。 COPD和气喘装置（也称为肺部药物输送装置）既可用于呼吸系统疾病的常规治疗，也可用于紧急治疗。因此，它们已引起全球的广泛关注。

慢性阻塞性肺病和气喘治疗设备的市场趋势：

人们越来越关注个人化医疗

随着製造商致力于提供针对每位患者个别需求的客製化解决方案，个人化医疗的兴起正对慢性阻塞性肺病（COPD）和气喘设备的市场份额产生显着影响。旨在提升患者舒适度和治疗精准度的可自订吸入器和雾化器正日益受到关注。个人化给药系统可确保药物精准输送，最大限度地减少副作用，并提高整体治疗效果。此外，针对呼吸系统疾病特定分子路径的生物製药的兴起，也推动了专用先进给药设备的应用。这种个人化方法能够更有效地管理慢性呼吸系统疾病。随着对这些客製化解决方案的需求不断增长，市场预计将持续扩张，这反映了呼吸系统治疗领域中个人化医疗的更广泛趋势。

吸入器设计方面的技术进步

根据慢性阻塞性肺病（COPD）和气喘治疗设备市场的最新趋势，吸入器技术的持续创新正在推动市场发展，并改变这些呼吸系统疾病的治疗方式。配备感测器和蓝牙连接功能的智慧吸入器能够即时监测药物使用和依从性。这项进步使患者和医护人员能够追踪吸入模式并调整治疗方案，从而改善疾病管理。行动应用程式的整合进一步增强了这一优势，这些应用程式提供提醒功能、症状追踪功能以及与临床医生共用数据的功能。随着数位健康解决方案的日益普及，对智慧吸入器的需求不断增长，从而推动了整个COPD和气喘设备市场的成长。

新兴市场需求不断成长

受新兴经济体需求的推动，慢性阻塞性肺病（COPD）和气喘治疗设备的市场规模正经历强劲成长。快速的都市化、日益严重的空气污染以及不断上升的吸烟率等因素，导致亚太、拉丁美洲和中东等地区呼吸系统疾病的盛行率不断上升。全球约有11亿15岁以上的吸烟者，其中80%居住在中低收入国家（LMIC）。吸烟率的上升，尤其是在青少年群体中，除非实施更严格的监管，否则将加重健康和经济负担。这些地区的政府和医疗卫生系统正在投资研发更好的诊断工具和治疗设备，以应对日益严重的COPD和气喘负担。此外，医疗服务可近性的提高以及携带式吸入器和雾化器的普及，也推动了这些地区的市场成长，使新兴市场成为未来扩张的关键枢纽。

目录

第一章：序言

第二章：调查方法

  • 调查目的
  • 相关利益者
  • 数据来源
    • 主要讯息
    • 二手资讯
  • 市场估值
    • 自下而上的方法
    • 自上而下的方法
  • 调查方法

第三章执行摘要

第四章：引言

第五章：全球慢性阻塞性肺病和气喘治疗设备市场

  • 市场概览
  • 市场表现
  • 新冠疫情的影响
  • 市场预测

第六章 市场区隔：依产品划分

  • 吸入器
    • 主要部分
      • 药物粉末吸入器（DPI）
      • 定量喷雾吸入器（MDI）
      • 缓雾吸入器
  • 喷雾器
    • 主要部分
      • 压缩式雾化器
      • 超音波雾化器
      • 筛孔式喷雾器

第七章 市场区隔：依应用领域划分

  • 气喘
  • COPD

第八章 市场区隔：依分销通路划分

  • 零售药房
  • 医院
  • 网路药房

第九章 市场区隔：依地区划分

  • 北美洲
    • 我们
    • 加拿大
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第十章 SWOT 分析

第十一章：价值链分析

第十二章：波特五力分析

第十三章：价格分析

第十四章 竞争格局

  • 市场结构
  • 主要企业
  • 主要企业简介
    • Adherium Limited
    • Aerogen Ltd
    • AptarGroup, Inc.
    • Boehringer Ingelheim Pharmaceuticals, Inc.
    • Cipla Limited
    • GF Health Products, Inc
    • GSK plc
    • PARI Respiratory Equipment, Inc.
    • ResMed
    • Teva Pharmaceuticals USA, Inc.
Product Code: SR112026A6126

The global COPD and asthma devices market size reached USD 49.9 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 72.5 Billion by 2034, exhibiting a growth rate (CAGR) of 4.24% during 2026-2034. The market growth is primarily driven by continual technological advancements in smart inhalers with real-time monitoring capabilities, growing prevalence of respiratory conditions, an enhanced emphasis on personalized treatment options for more accurate drug delivery and increasing demand in emerging markets due to improved healthcare access.

Chronic obstructive pulmonary disease (COPD) is an inflammatory disease that leads to obstructed airflow from the lungs. Its early symptoms include shortness of breath, wheezing, chest tightness, chronic cough with or without mucus, frequent cold, and throat soreness. On the other hand, asthma, also known as bronchial asthma, is a respiratory disorder that affects the airways in the lungs. Its symptoms are shortness of breath, chest tightness, trouble sleeping, and coughing or wheezing attacks. These respiratory diseases are treated using various devices that help deliver inhaled medication. COPD and asthma devices, also known as pulmonary drug delivery devices, are used as permanent treatment or rescue therapy for respiratory diseases. As a result, they are gaining immense traction across the globe.

COPD AND ASTHMA DEVICES MARKET TRENDS:

Increased Focus on Personalized Treatment Options

The shift towards personalized medicine is causing a substantial effect on the COPD and asthma devices market share, as manufacturers focus on offering solutions tailored to individual patient requirements. Customizable inhalers and nebulizers are becoming more prominent, designed to enhance patient comfort and treatment precision. Personalized dosing systems ensure accurate medication delivery, minimizing side effects and augmenting overall treatment effectiveness. Additionally, the rise of biologic therapies targeting specific molecular pathways involved in respiratory conditions, is encouraging the use of specialized and advanced delivery devices. This personalized approach allows for more effective management of chronic respiratory diseases. As demand for these customized solutions grows, the market is expected to expand, reflecting a broader trend towards individualized healthcare in respiratory treatment.

Technological Advancements in Inhaler Design

Ongoing innovations in inhaler technology are leading the market according to the latest COPD and asthma devices market trends, transforming the management of these respiratory conditions. Smart inhalers, equipped with sensors and Bluetooth connectivity, enable real-time monitoring of medication usage and adherence. This advancement allows patients and healthcare providers to track inhalation patterns and adjust treatments for improved disease control. The integration of mobile apps further supports this by offering reminders, symptom tracking, and data sharing with clinicians. As digital health solutions gain wider adoption, the demand for smart inhalers is rising, which is contributing to the overall growth of the COPD and asthma devices market.

Rising Demand in Emerging Markets

The COPD and asthma devices market size is witnessing strong growth in demand from emerging economies. Factors such as rapid urbanization, rising air pollution levels, and higher smoking rates are contributing to the prevalence of respiratory conditions in regions such as Asia-Pacific, Latin America, and the Middle East. Around 1.1 billion individuals over the age of 15 and over smoke, with 80% residing in low and middle income countries (LMICs). Rising smoking rates, especially among adolescents, pose growing health and economic burdens without stricter controls. Governments and healthcare systems in these regions are investing in better diagnostic tools and treatment devices to address the growing burden of COPD and asthma. Additionally, improved access to healthcare and the increasing adoption of portable inhalers and nebulizers are augmenting market growth in these regions, making emerging markets key centres for future expansion.

COPD AND ASTHMA DEVICES MARKET SEGMENTATION:

Breakup by Product:

  • Inhalers
    • Drug Powdered Inhalers (DPIs)
    • Metered Dose Inhalers (MDIs)
    • Soft Mist Inhalers
  • Nebulizers
    • Compressor Nebulizers
    • Ultrasonic Nebulizers
    • Mesh Nebulizers

Breakup by Indication:

  • Asthma
  • COPD

Breakup by Distribution Channel:

  • Retail Pharmacies
  • Hospitals
  • Online Pharmacies

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

COMPETITIVE LANDSCAPE:

The report has also provided a comprehensive analysis of the competitive landscape in the global COPD and asthma devices market. Detailed profiles of all major companies have also been provided. Some of the companies covered include:

  • Adherium Limited
  • Aerogen Ltd
  • AptarGroup, Inc.
  • Boehringer Ingelheim Pharmaceuticals, Inc.
  • Cipla Limited
  • GF Health Products, Inc
  • GSK plc
  • PARI Respiratory Equipment, Inc.
  • ResMed
  • Teva Pharmaceuticals USA, Inc.

KEY QUESTIONS ANSWERED IN THIS REPORT

1. What was the size of the global COPD and asthma devices market in 2025?

2. What is the expected growth rate of the global COPD and asthma devices market during 2026-2034?

3. What are the key factors driving the global COPD and asthma devices market?

4. What has been the impact of COVID-19 on the global COPD and asthma devices market?

5. What is the breakup of the global COPD and asthma devices market based on the product?

6. What is the breakup of the global COPD and asthma devices market based on the indication?

7. What is the breakup of the global COPD and asthma devices market based on distribution channel?

8. What are the key regions in the global COPD and asthma devices market?

9. Who are the key players/companies in the global COPD and asthma devices market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COPD and Asthma Devices Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Inhalers
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Drug Powdered Inhalers (DPIs)
      • 6.1.2.2 Metered Dose Inhalers (MDIs)
      • 6.1.2.3 Soft Mist Inhalers
    • 6.1.3 Market Forecast
  • 6.2 Nebulizers
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Compressor Nebulizers
      • 6.2.2.2 Ultrasonic Nebulizers
      • 6.2.2.3 Mesh Nebulizers
    • 6.2.3 Market Forecast

7 Market Breakup by Indication

  • 7.1 Asthma
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 COPD
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Distribution Channel

  • 8.1 Retail Pharmacies
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Online Pharmacies
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Adherium Limited
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Aerogen Ltd
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AptarGroup, Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Boehringer Ingelheim Pharmaceuticals, Inc.
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 Cipla Limited
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GF Health Products, Inc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 GSK plc
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 PARI Respiratory Equipment, Inc.
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 ResMed
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Teva Pharmaceuticals USA, Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COPD and Asthma Devices Market: Major Drivers and Challenges
  • Figure 2: Global: COPD and Asthma Devices Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: COPD and Asthma Devices Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 4: Global: COPD and Asthma Devices Market: Breakup by Product (in %), 2025
  • Figure 5: Global: COPD and Asthma Devices Market: Breakup by Indication (in %), 2025
  • Figure 6: Global: COPD and Asthma Devices Market: Breakup by Distribution Channel (in %), 2025
  • Figure 7: Global: COPD and Asthma Devices Market: Breakup by Region (in %), 2025
  • Figure 8: Global: COPD and Asthma Devices (Inhalers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 9: Global: COPD and Asthma Devices (Inhalers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 10: Global: COPD and Asthma Devices (Nebulizers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 11: Global: COPD and Asthma Devices (Nebulizers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 12: Global: COPD and Asthma Devices (Asthma) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 13: Global: COPD and Asthma Devices (Asthma) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 14: Global: COPD and Asthma Devices (COPD) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 15: Global: COPD and Asthma Devices (COPD) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 16: Global: COPD and Asthma Devices (Retail Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 17: Global: COPD and Asthma Devices (Retail Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 18: Global: COPD and Asthma Devices (Hospitals) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 19: Global: COPD and Asthma Devices (Hospitals) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 20: Global: COPD and Asthma Devices (Online Pharmacies) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 21: Global: COPD and Asthma Devices (Online Pharmacies) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 22: North America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 23: North America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 24: United States: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 25: United States: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 26: Canada: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 27: Canada: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 28: Asia-Pacific: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 29: Asia-Pacific: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 30: China: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 31: China: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 32: Japan: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 33: Japan: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 34: India: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 35: India: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 36: South Korea: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 37: South Korea: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 38: Australia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 39: Australia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 40: Indonesia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 41: Indonesia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 42: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 43: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 44: Europe: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 45: Europe: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 46: Germany: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 47: Germany: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 48: France: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 49: France: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 50: United Kingdom: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 51: United Kingdom: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 52: Italy: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 53: Italy: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 54: Spain: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 55: Spain: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 56: Russia: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 57: Russia: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 58: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 59: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 60: Latin America: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 61: Latin America: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 62: Brazil: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 63: Brazil: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 64: Mexico: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 65: Mexico: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 66: Others: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 67: Others: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 68: Middle East and Africa: COPD and Asthma Devices Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 69: Middle East and Africa: COPD and Asthma Devices Market: Breakup by Country (in %), 2025
  • Figure 70: Middle East and Africa: COPD and Asthma Devices Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: Global: COPD and Asthma Devices Industry: SWOT Analysis
  • Figure 72: Global: COPD and Asthma Devices Industry: Value Chain Analysis
  • Figure 73: Global: COPD and Asthma Devices Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COPD and Asthma Devices Market: Key Industry Highlights, 2025 & 2034
  • Table 2: Global: COPD and Asthma Devices Market Forecast: Breakup by Product (in Million USD), 2026-2034
  • Table 3: Global: COPD and Asthma Devices Market Forecast: Breakup by Indication (in Million USD), 2026-2034
  • Table 4: Global: COPD and Asthma Devices Market Forecast: Breakup by Distribution Channel (in Million USD), 2026-2034
  • Table 5: Global: COPD and Asthma Devices Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 6: Global: COPD and Asthma Devices Market: Competitive Structure
  • Table 7: Global: COPD and Asthma Devices Market: Key Players